Economic evaluation of cholinesterase inhibitor therapy for dementia: comparison of Alzheimer's disease and Dementia with Lewy bodies.
OBJECTIVE: To assess the cost effectiveness of cholinesterase inhibitor (ChEI) treatment in patients with Alzheimer's disease (AD) and Dementia with Lewy bodies (DLB). METHOD: We used 4-month open label follow-up data from routine memory clinic patients. There were 852 patients with AD and 112...
Main Authors: | Gustavsson, A, Van Der Putt, R, Jönsson, L, Mcshane, R |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2009
|
Similar Items
-
Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease.
by: Rolinski, M, et al.
Published: (2012) -
Cholinesterase inhibitors reduce cortical Abeta in dementia with Lewy bodies.
by: Ballard, C, et al.
Published: (2007) -
Cholinesterase inhibitor treatment increases phosphotau accumulation in Alzheimer's disease but reduces A beta in dementia with Lewy bodies
by: Chalmers, K, et al.
Published: (2008) -
Anosmia in dementia is associated with Lewy bodies rather than Alzheimer's pathology.
by: McShane, R, et al.
Published: (2001) -
Biomarkers for the diagnosis of Alzheimer’s disease, dementia Lewy body, frontotemporal dementia and vascular dementia
by: Shifu Xiao, et al.
Published: (2019-02-01)